Pooled analysis finds levels 60 ng/mL are most protective among women aged 55 years and older
A post-hoc analysis of the VIDA study sought to determine if vitamin D levels influence risk for cancer and/or cancer prevention.
Just over half of patients in a standard therapy group had normal bone mineral density after a mean follow-up of 6 years; this contrasted with 93% of patients in a vitamin D supplementation group.
Supplementation with vitamin D3 in premenopausal women does not have a significant effect on breast density percentage, nor does it reduce breast cancer risk.
Vitamin D and androgen receptor-targeted therapy successfully reduced growth and induced death of cancerous cells in a cell culture model of triple-negative breast cancer.
Higher serum levels of 25-hydroxyvitamin D (25(OH)D) correlated with a reduced risk of cancer in women.
People residing at higher latitudes, who are exposed to lower levels of sunlight/ultraviolet B light and have a higher prevalence of vitamin D deficiency, are at least twice as likely to develop leukemia than equatorial populations.
Dietary supplementation with vitamin D and/or calcium after removal of precancerous colorectal adenomas (polyps) does not reduce risk of developing future adenomas.
In patients with metastatic colorectal cancer treated with chemotherapy plus biologics, increased vitamin D levels have been linked to improved survival, according to information presented at the ASCO 2015 Annual Meeting.
A lower vitamin D levels prior to treatment for follicular lymphoma has been linked to earlier relapse and increased mortality, according to a new study.
Bruce W. Hollis, PhD, discusses the findings from his study on the benefits of increasing vitamin D intake in patients with prostate cancer undergoing active surveillance.
Neither circulating 25-hydroxyvitamin D (25[OH]D) levels nor common variations in vitamin D pathway genes appear to be associated with risk of fatal prostate cancer, according to recent research.
Vitamin D can protect some people with colorectal cancer by ramping up the immune system's vigilance against tumor cells, according to new research.
Patients in a a phase III study with higher vitamin D levels demonstrated better outcomes after treatment for their colorectal cancer with chemotherapy and targeted therapy.
Certain types of cancer patients tended to have lower vitamin D levels
Cancer patients who have higher levels of vitamin D at diagnosis tend to have better survival rates and remain in remission longer than patients who are vitamin D-deficient, according to a new study.
Sign Up for Free e-newsletters
- Is Radioimmunotherapy a Path Forward for Melanoma?
- FDA Approves Mogamulizumab-kpkc for Rare Subtypes of Non-Hodgkin Lymphoma
- New PDL1 Inhibitors for Non-small Cell Lung Cancer: Focus on Pembrolizumab
- Intensive Chemotherapy May Not Be Effective in MDS or AML After MDS
- ASCO Endorses SIO Guideline for Integrative Therapies in Breast Cancer
- Seeking Reliable Information on Herbal Products
- NCCIH HerbList App Launched to Provide Information on Herbal Products
- Metformin Use May Improve Survival Outcomes in Bladder Cancer
- Higher Vitamin D Levels Associated With Lower Breast Cancer Risk
- Nurse-Led Program Improves Health, Financial Outcomes in Outpatient Chemotherapy
- Adhering to Cytoreductive Therapy Use May Improve Outcomes in Polycythemia Vera
- Disparities Remain in Prevalence of Cancer Screening Tests
- Hope, Gratitude, and Spirituality: What They Mean to Cancer Patients
- FDA, EU Approvals Sought for Split Dose Regimen of Daratumumab for Multiple Myeloma
- 8 Hours of Bedrest May Be Ideal After Intrathecal Chemotherapy in Hematologic Cancers
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|